Historique de carrière de Robert Glanzman
Anciens postes connus de Robert Glanzman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CLENE INC. | Directeur Technique/Scientifique/R&D | 01/07/2019 | 01/04/2023 |
| GENEURO SA | Directeur Technique/Scientifique/R&D | 01/12/2015 | 30/06/2019 |
| University of Michigan | Corporate Officer/Principal | - | - |
| Pfizer AG | Directeur Technique/Scientifique/R&D | - | - |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01/01/2013 | - |
Purdue Pharmaceuticals LP
 Purdue Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Part of Purdue Pharma LP, Purdue Pharmaceuticals LP is a physician-founded and physician-led company that develops, manufactures, and markets medications and consumer health products. Purdue Pharmaceuticals is based in Wilson, NC and offers a diverse product line. The company is committed to supporting collaborations to drive innovations in patient care while addressing the opioid addiction crisis. | Corporate Officer/Principal | 01/01/2012 | - |
Formation de Robert Glanzman
| Wake Forest School of Medicine | Doctorate Degree |
| The University of North Carolina at Charlotte | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Suisse | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| GENEURO SA | Health Technology |
| CLENE INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Pfizer AG | |
Purdue Pharmaceuticals LP
Purdue Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Part of Purdue Pharma LP, Purdue Pharmaceuticals LP is a physician-founded and physician-led company that develops, manufactures, and markets medications and consumer health products. Purdue Pharmaceuticals is based in Wilson, NC and offers a diverse product line. The company is committed to supporting collaborations to drive innovations in patient care while addressing the opioid addiction crisis. | Health Technology |
- Bourse
- Insiders
- Robert Glanzman
- Expérience
